Peptide record

TPDB92074

Ple-a Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity modified_plain modified
25 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB92074
Ple-a
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia CancerPPD 2.0 SATPdb dbACP Antifungipept CAFPdb i2APP APD_complete HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
modified_plain
Yes
A 25-aa modified multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
C-terminal: Amidation
Sequence
GWGSFFKKAAHVGKHVGKAALTHYL-NH2
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
25 reviewed residue count
Amidation Activity
L Activity
Linear Activity
Free Activity
Antimicrobial Activity
C-terminal-amidated derivative of Pleurocidin Activity
Evidence Records 6 records
Evidence 1 Activity

Activity

IC50
IC50 = 11 µM
Anticancer
11 µM

Target

Liver Cancer
J5
Liver

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2022

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50 = 60 µM
Anticancer
60 µM

Target

Liver Cancer
Huh-7
Liver

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2022
Evidence 3 Activity

Activity

IC50
IC50 = 77.5 µM
Anticancer
77.5 µM

Target

Liver Cancer
Hep3B
Liver

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2022
Evidence 4 Activity

Activity

IC50
IC50 = 42.1 µM
Anticancer
42.1 µM

Target

Lung Cancer
A-549
Lung

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2022
Evidence 5 Activity

Activity

IC50
IC50 = 29.8 µM
Anticancer
29.8 µM

Target

Stomach Cancer
AGS
Stomach

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2022
Evidence 6 Activity

Activity

IC50
IC50 = 197.3 µM
Anticancer
197.3 µM

Target

Colon Cancer
WiDr
Colon

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2022